文献速递脊柱关节炎

新型银屑病关节炎超声附着点炎评分DUET的开发与验证

The development and validation of a new diagnostic sonographic enthesitis score for psoriatic arthritis: Diagnostic Ultrasound Enthesitis Tool (DUET).
PubMed 文献 · Arthritis Rheumatol · 2026-10-28

DUET研究前瞻性纳入早期PsA、无关节炎的银屑病和对照组,开发并验证了一种新的超声附着点炎评分系统以辅助PsA诊断。该评分结合三个附着点部位的加权炎症和结构病变评分,并按年龄分层设定截断值,在验证队列中特异度提高至74-100%,敏感性相似,在附着点压痛患者中敏感性可达63%。

要点

  • DUET评分基于Achilles、髌腱近端止点和三头肌三个附着点部位的加权炎症与结构评分。
  • 年龄分层(≤55岁 vs >55岁)可改善判别性能,截断值设定以维持特异度>70%。
  • 外部验证队列中特异度74-100%,敏感性49-52%,附着点压痛患者敏感性可达63%。

核心结论

  • DUET是一种新型、经外部验证的超声附着点炎评分,可支持早期PsA的诊断评估,尤其在附着点压痛患者中。

研究设计与样本

  • 前瞻性多中心研究,从17个中心纳入早期PsA、无关节炎的银屑病(PsO)和non-inflammatory musculoskeletal symptoms对照(CTL)。
  • 发现队列包括213例PsA、100例PsO和106例CTL;外部验证队列包括101例PsA和69例CTL。
  • 对16个附着点部位进行标准化超声评估,图像由三名盲法读者集中评分炎症和结构病变。
  • 采用按年龄分层的logistic回归模型逐步筛选最佳病变组合、权重和附着点部位,年龄特异性截断值设定以维持特异度>70%。

主要发现

  • 最终DUET评分结合三个附着点部位(Achilles、髌腱近端止点、三头肌)的加权炎症评分(低回声+增厚+多普勒分级×2)和结构评分(附着点骨赘分级+侵蚀×3)。
  • 年龄分层(≤55岁 vs >55岁)改善判别性能。
  • 发现队列中DUET的AUC为0.65,特异度73-74%,敏感性47-49%。
  • 外部验证队列中特异度提高至74-100%,敏感性相似(49-52%)。
  • 附着点压痛患者中敏感性增加至63%。

关键数值与推荐

  • DUET评分权重:炎症评分=低回声+增厚+多普勒分级×2;结构评分=附着点骨赘分级+侵蚀×3。
  • 评估部位:Achilles、髌腱近端止点、三头肌。
  • 年龄分层:≤55岁 vs >55岁,截断值设定以维持特异度>70%。
  • 发现队列AUC 0.65,特异度73-74%,敏感性47-49%;外部验证队列特异度74-100%,敏感性49-52%。

临床怎么用

  • DUET评分可用于早期PsA的诊断支持,尤其适用于附着点压痛患者。
  • 超声评估应涵盖Achilles、髌腱近端止点和三头肌三个附着点部位,并分别评分炎症和结构病变。
  • 应用年龄特异性截断值(≤55岁 vs >55岁)以提高判别性能。

局限性

  • 发现队列中AUC为0.65,判别性能中等。
  • 敏感性相对较低(47-52%),在无附着点压痛患者中可能更低。
  • 外部验证队列样本量较小(101例PsA和69例CTL)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Diagnostic Ultrasound Enthesitis Tool (DUET) study aimed to develop and validate a new sonographic scoring system for enthesitis to aid PsA diagnosis. METHODS: We prospectively enrolled patients with early PsA, psoriasis without arthritis (PsO), and non-inflammatory musculoskeletal symptoms as controls (CTL) from 17 centers. A standardized ultrasound assessment of 16 entheseal sites was performed and images were centrally scored by three blinded readers for inflammatory and structural entheseal lesions. Using a stepwise approach with logistic regression models stratified by age, we identified optimal lesion combinations, weightings, and entheseal sites for distinguishing PsA from CTL. Age-specific cut-off points were selected to maintain specificity above 70%. Performance was assessed in a validation cohort of PsA and CTL. RESULTS: We included 213 PsA, 100 PsO, and 106 CTL in the discovery cohort. The final DUET score combined weighted inflammatory (hypoechogenicity + thickening + Doppler grade x 2) and structural (enthesophyte grade + erosion x 3) scores at three entheseal sites: Achilles, proximal patellar tendon insertion, and triceps. Age stratification (≤55 vs. >55 years) improved discriminative performance. In the discovery cohort, DUET achieved an AUC of 0.65, with specificity of 73-74% and sensitivity of 47-49%. In an external validation cohort (101 PsA, 69 CTL), specificity improved to 74-100% with similar sensitivity (49-52%). Sensitivity increased up to 63% in patients with tender entheses. CONCLUSION: DUET is a novel, externally validated sonographic enthesitis score that could support the diagnostic assessment of patients with early PsA, particularly in individuals with tender entheses.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Eder L, Ribeiro AL, de Toledo RA, et al. The development and validation of a new diagnostic sonographic enthesitis score for psoriatic arthritis: Diagnostic Ultrasound Enthesitis Tool (DUET). Arthritis Rheumatol. 2026. PMID: 42949213. doi:10.1002/art.70384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。